Lipid lowering agents to delay cognitive decline in Alzheimer's disease?

J Neurol Neurosurg Psychiatry. 2005 Dec;76(12):1611-3. doi: 10.1136/jnnp.2005.076315.
No abstract available

Publication types

  • Comment

MeSH terms

  • Alzheimer Disease / complications*
  • Alzheimer Disease / physiopathology
  • Cholesterol
  • Cognition Disorders / drug therapy*
  • Cognition Disorders / etiology*
  • Humans
  • Hypolipidemic Agents / pharmacology
  • Hypolipidemic Agents / therapeutic use*
  • Treatment Outcome

Substances

  • Hypolipidemic Agents
  • Cholesterol